Maitreya Medicare Limited IPO : Maitreya Medicare Limited’s IPO is set to launch on October 27, 2023, and will conclude on November 1, 2023. Investors can purchase shares in the price range of ₹78 to ₹82 per share, with a minimum lot size of 1600 shares for an application. The allotment process is expect to be completed by November 6, 2023, follow by refunds beginning on November 7, and shares being credit to demat accounts on November 8.
Maitreya Medicare Limit’s IPO is tentatively scheduled to be list on NSE SME on November 9, 2023. As with any IPO investment, it is important for investors to conduct thorough research and analysis before making a decision. Are you an investor looking for the next big opportunity in the stock market? Well, look no further than Maitreya Medicare Limited. This upcoming IPO has been generating a lot of buzz in the financial world, and for good reason.
Maitreya Medicare Limited IPO
Maitreya Medicare Limited IPO is a company that offers an extensive range of medical services across 18 specialties and super-specialties. These include cardiology, urology, oncology, laparoscopic surgery, neurology, neurosurgery, spine surgery, nephrology (including dialysis), gastroenterology, gastrointestinal surgery, cardiothoracic surgery, microsurgery, orthopedic surgery (including joint replacements and arthroscopic surgeries), and gynecology & high-risk obstetrics.
The hospital also offers essential support services like Pathology and Radiology, including CT scans. Maitreya Medicare Hospital has expand its capacity from 67 beds in 2021 to 100 beds in 2022 and now to an impressive 125 beds in 2023. This shows a commitment to providing top-notch medical care to more patients than ever before. With these advancements, Maitreya Medicare is poised to maintain its status as a leader in the healthcare industry.
Maitreya Medicare Limited IPO Details
| IPO Open | October 27, 2023 |
| IPO Close | November 1, 2023 |
| Face Value | ₹10 per share |
| Price Band | ₹78 to ₹82 per share |
| Lot Size | 1600 Shares |
| Total Issue Size | 1,816,000 shares (aggregating up to ₹14.89 Cr) |
| Fresh Issue | 1,816,000 shares (aggregating up to ₹14.89 Cr) |
| Retail Quota | 35% |
| QIB Quota | 50% |
| NII Quota | 15% |
| Basis of Allotment | November 6, 2023 |
| Initiation of Refunds | November 7, 2023 |
| The credit of Shares to Demat | November 8, 2023 |
| Listing Date | November 9, 2023 |
| IPO Listing on | NSE SME |
| Category | News |
| Official Website | Click Here |
 |
|
 |
|
| Telegram |  |
Also Check: Arjun Kapoor Spoke About Sridevi
Maitreya Medicare IPO grey market premium (GMP)
Session 2 mark the start of the GMP for the SME IPO of Maitreya Medicare Limit. It is currently uncertain how the GMP will progress in the future. We encourage you to check back regularly for the latest GMP updates and additional information, which we update on a daily basis. For more details on the daily performance of the GMP and the expect listing price for Maitreya Medicare Limit SME IPO, please continue reading.
Grey Market Premium
The phrase “grey market premium” (GMP) pertains to the higher price at which an IPO is sold on the unofficial market before its official listing. The GMP indicates the potential range of outcomes for a company’s IPO when it becomes list. A positive GMP premium suggests that investors may expect a return on their investment from the initial public offering, while a negative GMP implies that they are likely to be getting a favorable deal.
Maitreya Medicare Limit SME
However, it is risky to make an investment decision solely bas on the IPO GMP of Maitreya Medicare Limit SME, as it tends to be highly volatile.In this blog post, we’ll take a closer look at what makes Maitreya Medicare Limit a potentially lucrative investment opportunity. From their strong financial performance to their innovative healthcare solutions, there’s a lot to be excited about. So, whether you’re a season investor or just starting out, keep reading to learn more about Maitreya Medicare Limit and why you should consider getting in on the ground floor of this IPO.
High-Quality Healthcare Services
The company aims to provide high-quality healthcare services to patients by leveraging the latest medical technologies and emphasizing patient-centere care. With a team of experience doctors and healthcare professionals, Maitreya Medicare Limit IPO is committed to improving the health outcomes of its patients. Maitreya Medicare Limit is a leading hospital that has made significant improvements to its facilities, including the addition of two Modular Superspeciality Operation Theatres with Laminar Air Flow and HEPA Filters, as well as a 20-bed Intensive Care Unit equip with ECMO and CRRT.
Check Here: Achar Sanhita In Rajasthan 2023
Maitreya Medicare Limited IPO Lot Size
Investors can bid for as little as 1600 shares or multiples of that number. Retail investors typically invest smaller sums, while HNIs invest larger amounts. Both types of investors can earn significant returns bas on market conditions, company performance, and economic trends.
- Retail (Min): 1600, ₹131,200
- Retail (Max):1600, ₹131,200
- HNI (Min): 3,200, ₹262,400
Maitreya Medicare Limited IPO Reservation
- QIB Shares Offered: Not More than 50% of the Net Issue
- Retail Shares Offered: Not less than 35% of the Net Issue
- NII (HNI) Shares Offered: Not less than 15% of the Net Issue
Objects Of The Issue (Maitreya Medicare Limited IPO)
The hospital plans to use the issue’s proceeds to accomplish the following goals:
- To construct a hospital in Valsad, Gujarat, an equity investment will be made in the subsidiary, Maitreya Hospital Private Limited.
- A portion of the Non-Convertible Redeemable Preference Shares that were issue are currently being redeem.
- The funds are required by the company to cover operational costs and achieve other corporate goals.
Look Here: ISRO Moon Mission Chandrayaan 3 Status Landing 23 August 2023
Maitreya Medicare IPO Review
Maitreya Medicare Limit (MML) is a multi-super specialty hospital locate in Surat, Gujarat that was found in 2019. The hospital houses 125 beds and offers integrate healthcare services for primary, secondary, and tertiary care. MML aims to increase the number of patients they serve and the occupancy rate of their rooms by expanding their facilities. They are commit to providing quality medical care and are continuously improving their services to meet the needs of their patients. MML plans to expand their healthcare services across the region and become a leading player in the healthcare industry.
Maitreya Medicare IPO Healthcare Industry
The hospital mention has a specialize focus on the healthcare industry in southern Gujarat and boasts a comprehensive understanding of its nuances, consumer culture, and medical professionals’ attitudes. As such, patients seeking medical assistance can benefit from the hospital’s extensive diagnostic services and pharmacy. The hospital’s deep familiarity with the industry allows it to provide tailored healthcare solutions that cater to the specific needs of patients in the region. By offering comprehensive services under one roof, patients can receive seamless and efficient care that prioritizes their well-being.
Read More: World’s first headphones with lossless hi-res audio support launched
How To check Maitreya Medicare Limited IPO Status?
If you’re eagerly waiting to invest in the Maitreya Medicare Limit IPO, you may be wondering how to check its status. The IPO market can be fast-pace and unpredictable, making it crucial to stay update on the latest information. In this blog post, we will guide you through the process of checking the Maitreya Medicare Limit IPO status, step by step. Whether you’re a season investor or new to the world of IPOs, this guide will help ensure that you never miss an opportunity to invest in this exciting company. So, let’s dive in and learn how to check the status of the Maitreya Medicare Limit IPO!
To inquire about the status of your Maitreya Medicare Limit IPO application, please follow these straightforward instructions:
- Please go to the designate website of the registrar assign for the Maitreya Medicare Limit initial public offering (IPO). The name of the registrar will be specified in either the IPO prospectus or the application form.
- Search for the option label “IPO Application Status” or a comparable alternative on the registrar’s website.
- Please provide the require information, such as your PAN (Permanent Account Number), Application Number, or Demat Account Number.
- Once you have provide the necessary information, you will have the ability to check the progress of your IPO application, which will indicate whether it has been approve, decline, or is currently being assess.
Who will announce the Maitreya Medicare Limited IPO?
The lead managers of the Maitreya Medicare Limit IPO will be responsible for announcing the launch of the offering. They are accountable for the end-to-end process, including determining the price and timing of the IPO, as well as marketing and distributing shares to potential investors. While it is likely that the lead managers will make an official announcement, Maitreya Medicare Limit itself may also release a statement regarding the IPO through various communication channels. It will be interesting to see how this IPO unfolds and what impact it has on the healthcare industry.
What to do if any discrepancy in Maitreya Medicare Limited IPO?
In case of any discrepancies encounter in Maitreya Medicare Limit IPO, the first step to take is to reach out to your broker or the registrar of the IPO. Providing them with all relevant details and documents pertaining to the discrepancy is crucial. However, if the issue persists even after contacting them, filing a complaint with Securities and Exchange Board of India (SEBI) through their online grievance redressal system can be another option. It is vital to address any discrepancies as soon as possible to protect your investment and ensure that you receive the shares that you are entitle to. Prompt action can mitigate potential risks and safeguard your financial interests.
Maitreya Medicare Limited IPO Next Year Exam Important Information
I’m sorry, but without sufficient information about the Maitreya Medicare Limit IPO, it is challenging to provide a relevant and informative output. To gain a comprehensive understanding of the IPO, additional context and details are necessary. This may include the expect launch date, pricing, company background, and other crucial aspects relate to the IPO. Without these details, it is difficult to expand on this topic further and provide valuable insights that can help potential investors make inform decisions. It is essential to conduct thorough research before investing in any IPO to mitigate risks and maximize returns.
Conclusion
Maitreya Medicare Limited IPO is generating a lot of buzz in the financial world. As a leading pharmaceutical company, Maitreya Medicare Limited has built a strong reputation for its high-quality healthcare products and services. With the IPO, the company aims to raise funds for expansion and further research and development. Investors are taking note of this opportunity to get in on the ground floor of a promising venture. The IPO is expected to attract significant interest from both institutional and retail investors, as Maitreya Medicare Limited has demonstrated consistent growth and profitability over the years. As the healthcare industry continues to thrive, investing in Maitreya Medicare Limited could be a wise choice for those looking to capitalize on this sector’s potential.
Related Post:
Biggest Economies of the World 2023
